Infant Bacterial Therapeutics AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118 and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.
/ 
Frequently asked questions
To buy Infant Bacterial Therapeutics AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Infant Bacterial Therapeutics AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Infant Bacterial Therapeutics AB is IBT_B:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Infant Bacterial Therapeutics AB has its primary listing on NASDAQ OMX Stockholm. You can trade Infant Bacterial Therapeutics AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Infant Bacterial Therapeutics AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Infant Bacterial Therapeutics AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Infant Bacterial Therapeutics AB.